https://orcid.org/0000-0003-1040-3746
Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Eslam M. Abbass, Ali Kh. Khalil, Yousra Abdel-Mottaleb & Mohamed S. A. Abdel-Mottaleb. (2024) Exploiting Modeling Studies for Evaluating the Potential Antiviral Activities of some Clinically Approved Drugs and Herbal Materials against SARS-CoV-2: Theoretical Studies toward Hindering the Virus and Blocking the Human Cellular Receptor. Polycyclic Aromatic Compounds 44:2, pages 1209-1220.
Read now
Read now
Jiandong Liu, Tianle Cang, Congli Jiang, Kelei Li, Siyuan Liu, Haixin Wang, Meirong Wang, Yan Chen, Yan Shao & Jiankai Liu. (2023) Cpg 684: An Effective Adjuvant for the Inactivated COVID-19 Vaccine in Mice. Future Virology 18:7, pages 403-410.
Read now
Read now
Meiyu Wang, Li Zhang, Qianqian Li, Bo Wang, Ziteng Liang, Yeqing Sun, Jianhui Nie, Jiajing Wu, Xiaodong Su, Xiaowang Qu, Yuhua Li, Youchun Wang & Weijin Huang. (2022) Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination. Emerging Microbes & Infections 11:1, pages 18-29.
Read now
Read now
Manish Dhawan, Abhilasha Sharma, Priyanka, Nanamika Thakur, Tridib Kumar Rajkhowa & Om Prakash Choudhary. (2022) Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, Talha Bin Emran, Saikat Mitra, Ali A. Rabaan, Saad Alhumaid, Zainab Al Alawi & Abbas Al Mutair. (2022) COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Md. Jamal Hossain, Ali A. Rabaan, Abbas Al Mutair, Saad Alhumaid, Talha Bin Emran, G Saikumar, Saikat Mitra & Kuldeep Dhama. (2022) Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Khan Sharun, Ruchi Tiwari, Kuldeep Dhama, Ali A. Rabaan & Saad Alhumaid. (2021) COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns. Human Vaccines & Immunotherapeutics 17:11, pages 4108-4111.
Read now
Read now
Articles from other publishers (19)
Joanne Thandrayen & Bernard Baffour. (2024) Gaining further insights into the COVID-19 pandemic in Australia: Evidence using capture-recapture methods. Heliyon 10:1, pages e23408.
Crossref
Crossref
Ying Lu, Fan Shen, Wen-Qiang He, An-Qi Li, Ming-Hua Li, Xiao-Li Feng, Yong-Tang Zheng & Wei Pang. (2023) HR121 targeting HR2 domain in S2 subunit of spike protein can serve as a broad-spectrum SARS-CoV-2 inhibitor via intranasal administration. Acta Pharmaceutica Sinica B 13:8, pages 3339-3351.
Crossref
Crossref
Qianru Sun, Jinfeng Zeng, Kang Tang, Haoyu Long, Chi Zhang, Jie Zhang, Jing Tang, Yuting Xin, Jialu Zheng, Litao Sun, Siyang Liu & Xiangjun Du. (2023) Variation in synonymous evolutionary rates in the SARS-CoV-2 genome. Frontiers in Microbiology 14.
Crossref
Crossref
Buasiyamu Abudunaibi, Weikang Liu, Zhinan Guo, Zeyu Zhao, Jia Rui, Wentao Song, Yao Wang, Qiuping Chen, Roger Frutos, Chenghao Su & Tianmu Chen. (2023) A comparative study on the three calculation methods for reproduction numbers of COVID-19. Frontiers in Medicine 9.
Crossref
Crossref
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, Mohd. Iqbal Yatoo, Ranjan K. Mohapatra, Sandip Chakraborty, Hao Zhou, Md. Rabiul Islam, Sukamto S. Mamada, Hendrix Indra Kusuma, Ali A. Rabaan, Saad Alhumaid, Abbas Al Mutair, Muhammad Iqhrammullah, Jaffar A. Al-Tawfiq, Mohammed Al Mohaini, Abdulkhaliq J. Alsalman, Hardeep Singh Tuli, Chiranjib Chakraborty & Harapan Harapan. (2023) Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. Journal of Infection and Public Health 16:1, pages 4-14.
Crossref
Crossref
Abdullahi Tunde Aborode, Helen Huang, Andrew Awuah Wireko, Aashna Mehta, Jacob Kalmanovich, Toufik Abdul‐Rahman, Vladyslav Sikora & Aeshah A. Awaji. (2022) Approaching COVID‐19 with epidemiological genomic surveillance and the sustainability of biodiversity informatics in Africa. Journal of Medical Virology 95:1.
Crossref
Crossref
Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, Jason C Wells, Shazia Ali, Sumathi Sivapalasingam, Yiping Sun, Rafia Bhore, Jingning Mei, Jutta Miller, Lisa Cupelli, Eduardo Forleo-Neto, Andrea T Hooper, Jennifer D Hamilton, Cynthia Pan, Viet Pham, Yuming Zhao, Romana Hosain, Adnan Mahmood, John D Davis, Kenneth C Turner, Yunji Kim, Amanda Cook, Bari Kowal, Yuhwen Soo, A Thomas DiCioccio, Gregory P Geba, Neil Stahl, Leah Lipsich, Ned Braunstein, Gary A Herman, George D Yancopoulos & David M Weinreich. (2023) Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19. The Journal of Infectious Diseases 227:1, pages 23-34.
Crossref
Crossref
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, Fahad A. Alhumaydhi, Talha Bin Emran & Polrat Wilairatana. (2022) Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?. Biomedicine & Pharmacotherapy 154, pages 113522.
Crossref
Crossref
Nancy Fayad, Walid Abi Habib, Rabeh El-Shesheny, Ahmed Kandeil, Youmna Mourad, Jacques Mokhbat, Ghazi Kayali, Jimi Goldstein & Jad Abdallah. (2022) Lebanese SARS-CoV-2 genomics: 24 months of the pandemic. Virus Research 317, pages 198824.
Crossref
Crossref
Shaza S. Issa, Sofia V. Sokornova, Roman R. Zhidkin & Tatiana V. Matveeva. (2022) The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus. Plants 11:14, pages 1862.
Crossref
Crossref
Abdul Hawil Abas, Siti Marfuah, Rinaldi Idroes, Diah Kusumawaty, Fatimawali, Moon Nyeo Park, Abolghasem Siyadatpanah, Fahad A. Alhumaydhi, Shafi Mahmud, Trina Ekawati Tallei, Talha Bin Emran & Bonglee Kim. (2022) Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?. Molecules 27:7, pages 2221.
Crossref
Crossref
Lixiao Xing, Xinfeng Xu, Wei Xu, Zezhong Liu, Xin Shen, Jie Zhou, Ling Xu, Jing Pu, Chan Yang, Yuan Huang, Lu Lu, Shibo Jiang & Shuwen Liu. (2022) A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern. Viruses 14:3, pages 597.
Crossref
Crossref
Antonio Sarría-Santamera, Nurlan Abdukadyrov, Natalya Glushkova, David Russell Peck, Paolo Colet, Alua Yeskendir, Angel Asúnsolo & Miguel A. Ortega. (2022) Towards an Accurate Estimation of COVID-19 Cases in Kazakhstan: Back-Casting and Capture–Recapture Approaches. Medicina 58:2, pages 253.
Crossref
Crossref
Trina Ekawati Tallei, Fatimawali, Ahmad Akroman Adam, Mona M. Elseehy, Ahmed M. El-Shehawi, Eman A. Mahmoud, Adinda Dwi Tania, Nurdjannah Jane Niode, Diah Kusumawaty, Souvia Rahimah, Yunus Effendi, Rinaldi Idroes, Ismail Celik, Md. Jamal Hossain & Talha Bin Emran. (2022) Fruit Bromelain-Derived Peptide Potentially Restrains the Attachment of SARS-CoV-2 Variants to hACE2: A Pharmacoinformatics Approach. Molecules 27:1, pages 260.
Crossref
Crossref
Manojit Bhattacharya, Srijan Chatterjee, Ashish Ranjan Sharma, Govindasamy Agoramoorthy & Chiranjib Chakraborty. (2021) D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity. Applied Microbiology and Biotechnology 105:24, pages 9035-9045.
Crossref
Crossref
Fahadul Islam, Shabana Bibi, Atkia Farzana Khan Meem, Md. Mohaimenul Islam, Md. Saidur Rahaman, Sristy Bepary, Md. Mizanur Rahman, Md. Mominur Rahman, Amin Elzaki, Samih Kajoak, Hamid Osman, Mohamed ElSamani, Mayeen Uddin Khandaker, Abubakr M. Idris & Talha Bin Emran. (2021) Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19. International Journal of Molecular Sciences 22:23, pages 12638.
Crossref
Crossref
SHIKA TAMTA, O R VINODHKUMAR, A KARTHIKEYAN, Z B DUBAL, SHARUN KHAN, ABDUL RAHMAN A SAIED, MANISH DHAWAN, KULDEEP DHAMA & Y S MALIK. (2021) Epidemiological profiling of SARS-CoV-2 with focus on one-health approaches in mitigating COVID-19 pandemic. The Indian Journal of Animal Sciences 91:10.
Crossref
Crossref
Md. Hossain, Tabassum Jannat, Shejuti Brishty, Urmi Roy, Saikat Mitra, Md. Rafi, Md. Islam, Mst. Nesa, Md. Islam & Talha Emran. (2021) Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far. Biologics 1:2, pages 252-284.
Crossref
Crossref
Ismail Celik, Rohitash Yadav, Zekeriya Duzgun, Sarah Albogami, Ahmed M. El-Shehawi, Fatimawali Fatimawali, Rinaldi Idroes, Trina Ekawati Tallei & Talha Bin Emran. (2021) Interactions of the Receptor Binding Domain of SARS-CoV-2 Variants with hACE2: Insights from Molecular Docking Analysis and Molecular Dynamic Simulation. Biology 10:9, pages 880.
Crossref
Crossref